Because we were interested in the effect of mTORC2 signaling on the therapeutic efficacy of PI3K inhibition in HNSCC tumor cells, we made use of the cBioPortal interface to evaluate whether aberrations in these genes (RICTOR and PIK3CA) tend to co‐occur or be exclusive from one another. This evidence concerns the gene RICTOR and head and neck squamous cell carcinoma.